Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 1
2004 1
2005 2
2007 4
2008 4
2009 4
2010 10
2011 5
2012 4
2013 8
2014 9
2015 10
2016 16
2017 14
2018 15
2019 21
2020 19
2021 18
2022 17
2023 3
Text availability
Article attribute
Article type
Publication date

Search Results

152 results
Results by year
Filters applied: . Clear all
Page 1
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Curigliano G, Shapiro GI, Kristeleit RS, Abdul Razak AR, Leong S, Alsina M, Giordano A, Gelmon KA, Stringer-Reasor E, Vaishampayan UN, Middleton M, Olszanski AJ, Rugo HS, Kern KA, Pathan N, Perea R, Pierce KJ, Mutka SC, Wainberg ZA. Curigliano G, et al. Among authors: abdul razak ar. Br J Cancer. 2023 Jan 25. doi: 10.1038/s41416-023-02161-w. Online ahead of print. Br J Cancer. 2023. PMID: 36697966 No abstract available.
Longitudinal efficacy and toxicity of SARS-CoV-2 vaccination in cancer patients treated with immunotherapy.
Spiliopoulou P, Janse van Rensburg HJ, Avery L, Kulasingam V, Razak A, Bedard P, Hansen A, Chruscinski A, Wang B, Kulikova M, Chen R, Speers V, Nguyen A, Lee J, Coburn B, Spreafico A, Siu LL. Spiliopoulou P, et al. Among authors: razak a. Cell Death Dis. 2023 Jan 20;14(1):49. doi: 10.1038/s41419-022-05548-4. Cell Death Dis. 2023. PMID: 36670100 Free PMC article.
Cranial Ultrasound Abnormalities in Small for Gestational Age or Growth-Restricted Infants Born over 32 Weeks Gestation: A Systematic Review and Meta-Analysis.
Roufaeil C, Razak A, Malhotra A. Roufaeil C, et al. Among authors: razak a. Brain Sci. 2022 Dec 14;12(12):1713. doi: 10.3390/brainsci12121713. Brain Sci. 2022. PMID: 36552172 Free PMC article. Review.
A random-effects model meta-analysis was performed. Risk of Bias was assessed using the Newcastle-Ottawa scale for case-control and cohort studies, and Joanna Briggs Institute Critical Appraisal Checklist for studies reporting prevalence data. ...
A random-effects model meta-analysis was performed. Risk of Bias was assessed using the Newcastle-Ottawa scale for case-control and c …
Adult Head and Neck Rhabdomyosarcoma: Management, Outcomes, and the Effect of Intensity Modulated Radiation Therapy on Locoregional Control.
Hahn E, Barot S, O'Sullivan B, Huang SH, Gupta A, Hosni A, Razak AA, Waldron J, Irish J, Gullane P, Brown D, Gilbert R, de Almeida JR, Tsang D, Shultz DB. Hahn E, et al. Among authors: razak aa. Adv Radiat Oncol. 2022 Aug 27;7(6):101055. doi: 10.1016/j.adro.2022.101055. eCollection 2022 Nov-Dec. Adv Radiat Oncol. 2022. PMID: 36420200 Free PMC article.
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.
Curigliano G, Shapiro GI, Kristeleit RS, Abdul Razak AR, Leong S, Alsina M, Giordano A, Gelmon KA, Stringer-Reasor E, Vaishampayan UN, Middleton M, Olszanski AJ, Rugo HS, Kern KA, Pathan N, Perea R, Pierce KJ, Mutka SC, Wainberg ZA. Curigliano G, et al. Among authors: abdul razak ar. Br J Cancer. 2023 Jan;128(1):30-41. doi: 10.1038/s41416-022-02025-9. Epub 2022 Nov 5. Br J Cancer. 2023. PMID: 36335217 Clinical Trial.
Seven of 70 (10.0%) evaluable patients had dose-limiting toxicities; the most common was grade 3 oral mucositis (n = 3). Based upon reprioritisation of the sponsor's portfolio, dose expansion focused on arm B, gedatolisib (180 mg QW) plus cisplatin in patients (N = 22) wit …
Seven of 70 (10.0%) evaluable patients had dose-limiting toxicities; the most common was grade 3 oral mucositis (n = 3). Based upon repriori …
Early phase oncology clinical trials in Malaysia: current status and future perspectives.
Voon PJ, Lai WH, Bustaman RS, Siu LL, Razak ARA, Yusof A, Abdullah NH. Voon PJ, et al. Among authors: razak ara. Asia Pac J Clin Oncol. 2022 Oct 28. doi: 10.1111/ajco.13886. Online ahead of print. Asia Pac J Clin Oncol. 2022. PMID: 36305522 Review.
Hence, the Phase 1 Realization Project was initiated to develop Malaysia's early phase clinical trial capabilities. In addition, the adaptation of good practices from other countries contribute to the effective implementation of existing initiatives to drive progress in th …
Hence, the Phase 1 Realization Project was initiated to develop Malaysia's early phase clinical trial capabilities. In addition, the …
Randomized Phase 2 Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma.
Nguyen J, Takebe N, Kummar S, Razak A, Chawla SP, George S, Patel SR, Keohan ML, Movva S, O'Sullivan Coyne G, Do K, Jawara L, Augustine B, Steinberg SM, Kuhlmann L, Ivy SP, Doroshow JH, Chen AP. Nguyen J, et al. Among authors: razak a. Clin Cancer Res. 2022 Oct 27:CCR-22-2145. doi: 10.1158/1078-0432.CCR-22-2145. Online ahead of print. Clin Cancer Res. 2022. PMID: 36302173
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.
Stacchiotti S, Maria Frezza A, Demetri GD, Blay JY, Bajpai J, Baldi GG, Baldini EH, Benjamin RS, Bonvalot S, Bovée JVMG, Callegaro D, Casali PG, D'Angelo SP, Davis EJ, Dei Tos AP, Demicco EG, Desai J, Dileo P, Eriksson M, Gelderblom H, George S, Gladdy RA, Gounder MM, Gupta AA, Haas R, Hayes A, Hohenberger P, Jones KB, Jones RL, Kasper B, Kawai A, Kirsch DG, Kleinerman ES, Le Cesne A, Maestro R, Martin Broto J, Maki RG, Miah AB, Palmerini E, Patel SR, Raut CP, Razak ARA, Reed DR, Rutkowski P, Sanfilippo RG, Sbaraglia M, Schaefer IM, Strauss DC, Strauss SJ, Tap WD, Thomas DM, Trama A, Trent JC, van der Graaf WTA, van Houdt WJ, von Mehren M, Wilky BA, Fletcher CDM, Gronchi A, Miceli R, Wagner AJ. Stacchiotti S, et al. Among authors: razak ara. Cancer Treat Rev. 2022 Nov;110:102455. doi: 10.1016/j.ctrv.2022.102455. Epub 2022 Aug 18. Cancer Treat Rev. 2022. PMID: 36031697 Review.
152 results